RI

Ruiyi Investment

Asia, Shanghai, China, Shanghai

Description

Ruiyi Investment seeks to create sustainable and stable returns for customers.

Investor Profile

Ruiyi Investment has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ruiyi Investment frequently co-invest with?

Hyde Capital
North America, California, United States, Santa Monica
Co-Investments: 1
China Capital Management
Asia, Beijing, China, Beijing
Co-Investments: 1
EFung Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Tigermed
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

Which angels does Ruiyi Investment often collaborate with?

Shared Deals: 1

What are some of recent deals done by Ruiyi Investment?

3D Medicines

Minhang, Shanghai, China

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownOct 9, 2020
Amount Raised: $140,000,000